BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q3 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,100,792 | -33.8% | 159,074 | -39.5% | 0.18% | -29.4% |
| Q3 2022 | $1,663,000 | -22.7% | 262,767 | -49.4% | 0.25% | +32.6% |
| Q2 2022 | $2,151,000 | -14.6% | 519,477 | -0.0% | 0.19% | -12.4% |
| Q1 2022 | $2,520,000 | -16.7% | 519,485 | +71.5% | 0.22% | -5.7% |
| Q4 2021 | $3,025,000 | -7.8% | 302,852 | +76.4% | 0.23% | -2.5% |
| Q3 2021 | $3,281,000 | +17.1% | 171,700 | +96.0% | 0.24% | +27.6% |
| Q2 2021 | $2,801,000 | +55.9% | 87,600 | +47.0% | 0.18% | +43.4% |
| Q1 2021 | $1,797,000 | -51.4% | 59,596 | -30.3% | 0.13% | -48.4% |
| Q4 2020 | $3,700,000 | -3.8% | 85,519 | +19.9% | 0.25% | -1.6% |
| Q3 2020 | $3,848,000 | -24.0% | 71,319 | -14.0% | 0.25% | -26.2% |
| Q2 2020 | $5,060,000 | +6.0% | 82,900 | -20.2% | 0.34% | -9.0% |
| Q1 2020 | $4,775,000 | -47.6% | 103,900 | 0.0% | 0.38% | -32.7% |
| Q4 2019 | $9,117,000 | +2167.9% | 103,900 | +896.3% | 0.56% | +5009.1% |
| Q2 2014 | $402,000 | – | 10,429 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |